Biocon

312.30

-14.10 (-4.32%) tick

BSE

Buy Sell

NSE BSE

Last updated on 25 Apr 2025 03:33 PM

Open Demat account

Returns

-5.89%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

39187.58

Earning Per Share

0.99

Dividend Yield

0.19%

P/E Ratio

266.77

P/B Ratio

3.60

Debt to Equity

0.15

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Biocon Limited is India's largest and fully-integrated, innovation-led biopharmaceutical company. Biocon, with its key business verticals of Generics, Biosimilars, Research Services and Novel Biologics, has leveraged its affordable innovation model and scientific capabilities to develop and manufacture both small and large molecules at global scale for the benefit of patients. At present, Company is engaged in the manufacture of biotechnology products and research services. Biocon Limited was incorporated in year 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind.

Similar Companies

Advanced Enzyme Tech

289.5 -8.75 (-0.03%) tick

1Yr Returns

-22.79%

Panacea Biotec

525 -13.35 (-0.02%) tick

1Yr Returns

+267.47%

Remus Pharmaceuticals L

1903.6 -52.75 (-0.03%) tick

1Yr Returns

-0.1%

Titan Biotech

484 -14.60 (-0.03%) tick

1Yr Returns

+0.61%

Vivo Bio Tech

39.45 -0.55 (-0.01%) tick

1Yr Returns

-11.44%